Your browser doesn't support javascript.
loading
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Marzolini, Maria A V; Mehra, Varun; Thomson, Kirsty J; Tholouli, Eleni; Bloor, Adrian J C; Parker, Anne; Lovell, Richard; Orchard, Kim; Publicover, Amy; Nicholson, Emma; Snowden, John A; Byrne, Jennifer; Khan, Anjum; Gilleece, Maria H; Errico, Gerardo; Lozano, Sara; Hurst, Erin; Duncan, Nick; Pirrie, Jennifer; Crea, Philip; Carpenter, Ben; Pagliuca, Antonio; Peggs, Karl S.
Afiliação
  • Marzolini MAV; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.
  • Mehra V; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Thomson KJ; Department of Haematology, Kings College Hospital, London, United Kingdom.
  • Tholouli E; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Bloor AJC; Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Parker A; Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Lovell R; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Orchard K; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Publicover A; Department of Haematology, University Hospital Southampton, Southampton, United Kingdom.
  • Nicholson E; Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  • Snowden JA; Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Byrne J; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Khan A; Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; and.
  • Gilleece MH; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Errico G; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Lozano S; Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; and.
  • Hurst E; Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Duncan N; Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  • Pirrie J; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Crea P; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Carpenter B; Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Pagliuca A; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Peggs KS; Department of Haematology, Kings College Hospital, London, United Kingdom.
Blood Adv ; 5(21): 4500-4503, 2021 11 09.
Article em En | MEDLINE | ID: mdl-34614515
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Infecções por Citomegalovirus Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Infecções por Citomegalovirus Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article